Characterization and cancer cell specific binding properties of anti-EGFR antibody conjugated quantum dots

Bioconjugate Chemistry

Volumn 21, Issue 5, 2010, Pages 940-946

  Lee, Junghan ^a   Choi, Youngseon ^a   Kim, Keumhyun ^a   Hong, Sukmin ^a   Park, Hye Young ^a   Lee, Taesup ^b   Cheon, Gi Jeong ^b   Song, Rita ^a  

^a Institute Pasteur Korea   (South Korea)

^b Korea Institute of Radiation and Medical Science   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CETUXIMAB; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY; MACROGOL; POLYMER; QUANTUM DOT; SULFOSUCCINIMIDYL 4 (N MALEIMIDOMETHYL)CYCLOHEXANE 1 CARBOXYLATE; SULFOSUCCINIMIDYL 6 [3' (2 PYRIDYLDITHIO)PROPIONAMIDO]HEXANOATE; TRANSFERRIN; UNCLASSIFIED DRUG;

ANTIBODY COMBINING SITE; ANTIBODY SPECIFICITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CELL LABELING; CELL SPECIFICITY; CELLULAR DISTRIBUTION; CONFOCAL LASER MICROSCOPY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DISSOCIATION CONSTANT; DRUG BINDING; DRUG COATING; DRUG CONJUGATION; ENDOCYTOSIS; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMAGE ANALYSIS; IN VITRO STUDY; INTERNALIZATION;

EID: 77952571662     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc9004975     Document Type: Article

References (23)

1. Chan, W. C. W. and Nie, S. M. (1998) Quantum dot bioconjugates for ultrasensitive nonisotopic detection Science 281, 2016-2018
2. Gao, X. H., Cui, Y. Y., Levenson, R. M., Chung, L. W. K., and Nie, S. M. (2004) In vivo cancer targeting and imaging with semiconductor quantum dots Nat. Biotechnol. 22, 969-976
3. Michalet, X., Pinaud, F. F., Bentolila, L. A., Tsay, J. M., Doose, S., Li, J. J., Sundaresan, G., Wu, A. M., Gambhir, S. S., and Weiss, S. (2005) Quantum dots for live cells, in vivo imaging, and diagnostics Science 307, 538-544
4. Bailey, R. E., Smith, A. M., and Nie, S. M. (2004) Quantum dots in biology and medicine Phys. E 25, 1-12
5. Pathak, S., Cao, E., Davidson, M. C., Jin, S. H., and Silva, G. A. (2006) Quantum dot applications to neuroscience: New tools for probing neurons and glia J. Neurosci. 26, 1893-1895
6. Hermanson, G. T. (2008) Zero-length crosslinkers. In Bioconjugate Techniques, pp 216 - 223, Elsevier Science, San Diego, CA.
7. Mendelsohn, J. (2002) Targeting the epidermal growth factor receptor for cancer therapy J. Clin. Oncol. 20, 1S-13S
8. Wong, S. F. (2005) Cetuximab: An epidermal growth factor receptor monoclonal antibody for the treatment of colorectal cancer Clinical Therapeutics 27, 684-694
9. Saltz, L. B., Meropol, N. J., Loehrer, P. J., Needle, M. N., Kopit, J., and Mayer, R. J. (2004) Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor J. Clin. Oncol. 22, 1201-1208
10. Johnstone, P. A. S. (2002) The epidermal growth factor receptor: A new target for anticancer therapy-Introduction Curr. Prob. Cancer 26, 114-164
11. Ritter, C. A. and Arteaga, C. L. (2003) The epidermal growth factor receptor-tyrosine kinase: A promising therapeutic target in solid tumors Semin. Oncol. 30, 3-11
12. Li, W. P., Meyer, L. A., Capretto, D. A., Sherman, C. D., and Anderson, C. J. (2008) Receptor-binding, biodistribution, and metabolism studies of Cu-64-DOTA-cetuximab, a PET-imaging agent for epidermal growth-factor receptor-positive tumors Cancer Biother. Radiopharm. 23, 158-171
13. Eiblmaier, M., Meyer, L. A., Watson, M. A., Fracassol, P. M., Pike, L. J., and Andersonl, C. J. (2008) Correlating EGFR expression with receptor-binding properties and internalization of Cu-64-DOTA-cetuximab in 5 cervical cancer cell lines J. Nucl. Med. 49, 1472-1479
14. Wu, G., Barth, R. F., Yang, W. L., Chatterjee, M., Tjarks, W., Ciesielski, M. J., and Fenstermaker, R. A. (2004) Site-specific conjugation of boron-containing dendrimers to anti-EGF receptor monoclonal antibody cetuximab (IMC-C225) and its evaluation as a potential delivery agent for neutron capture therapy Bioconjugate Chem. 15, 185-194
15. Yang, Y. A., Wu, H. M., Williams, K. R., and Cao, Y. C. (2005) Synthesis of CdSe and CdTe nanocrystals without precursor injection Angew. Chem., Int. Ed. 44, 6712-6715
16. Peng, Z. A. and Peng, X. G. (2001) Formation of high-quality CdTe, CdSe, and CdS nanocrystals using CdO as precursor J. Am. Chem. Soc. 123, 183-184
17. Yu, W. W., Qu, L. H., Guo, W. Z., and Peng, X. G. (2003) Experimental determination of the extinction coefficient of CdTe, CdSe, and CdS nanocrystals Chem. Mater. 15, 2854-2860
18. Rosenthal, S. J., Tomlinson, A., Adkins, E. M., Schroeter, S., Adams, S., Swafford, L., McBride, J., Wang, Y. Q., DeFelice, L. J., and Blakely, R. D. (2002) Targeting cell surface receptors with ligand-conjugated nanocrystals J. Am. Chem. Soc. 124, 4586-4594
19. Pathak, S., Davidson, M. C., and Silva, G. A. (2007) Characterization of the functional binding properties of antibody conjugated quantum dots Nano Lett. 7, 1839-1845
20. Walther, C., Meyer, K., Rennert, R., and Neundorf, I. (2008) Quantum dot-carrier peptide conjugates suitable for imaging and delivery applications Bioconjugate Chem. 19, 2346-2356
21. Liu, G., Lin, Y. Y., Wang, J., Wu, H., Wai, C. M., and Lin, Y. (2007) Disposable electrochemical immunosensor diagnosis device based on nanoparticle probe and immunochromatographic strip Anal. Chem. 79, 7644-7653
22. Haeder, M., Rotsch, M., Bepler, G., Hennig, C., Havemann, K., Heimann, B., and Moelling, K. (1988) Epidermal growth factor receptor expression in human lung cancer cell lines Cancer Res. 48, 1132-1136
23. Milenic, D. E., Wong, K. J., Baidoo, K. E., Ray, G. L., Garmestani, K., Williams, M., and Brechbiel, M. W. (2008) Cetuximab: preclinical evaluation of a monoclonal antibody targeting EGFR for radioimmunodiagnostic and radioimmunotherapeutic applications Cancer Biother. Radiopharm. 23, 619-631